Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$884K Buy
8,108
+1
+0% +$104 0.31% 58
2023
Q3
$835K Buy
8,107
+1
+0% +$108 0.31% 58
2023
Q2
$935K Buy
8,106
+1
+0% +$114 0.36% 55
2023
Q1
$862K Hold
8,105
0.32% 60
2022
Q4
$899K Buy
8,105
+676
+9% +$69.1K 0.35% 61
2022
Q3
$640K Sell
7,429
-175
-2% -$15.6K 0.27% 61
2022
Q2
$693K Buy
7,604
+175
+2% +$15.5K 0.26% 62
2022
Q1
$610K Hold
7,429
0.2% 65
2021
Q4
$569K Sell
7,429
-131
-2% -$10.4K 0.19% 65
2021
Q3
$568K Sell
7,560
-262
-3% -$19.9K 0.2% 63
2021
Q2
$608K Buy
7,822
+36
+0.5% +$2.68K 0.21% 62
2021
Q1
$573K Hold
7,786
0.22% 62
2020
Q4
$608K Buy
7,786
+79
+1% +$6.04K 0.24% 57
2020
Q3
$610K Buy
7,707
+16
+0.2% +$1.25K 0.27% 56
2020
Q2
$568K Buy
7,691
+613
+9% +$46.1K 0.28% 58
2020
Q1
$520K Sell
7,078
-264
-4% -$20.7K 0.3% 52
2019
Q4
$637K Sell
7,342
-346
-5% -$28.4K 0.31% 51
2019
Q3
$618K Hold
7,688
0.32% 53
2019
Q2
$615K Buy
7,688
+4,192
+120% +$321K 0.32% 52
2019
Q1
$277K Buy
3,496
+301
+9% +$22.5K 0.16% 68
2018
Q4
$233K Sell
3,195
-10
-0.3% -$706 0.15% 72
2018
Q3
$217K Sell
3,205
-413
-11% -$26.3K 0.15% 78
2018
Q2
$210K Buy
+3,618
New +$204K 0.16% 78
2017
Q3
Sell
-8,091
Closed -$495K 86
2017
Q2
$495K Sell
8,091
-517
-6% -$31.5K 0.43% 46
2017
Q1
$522K Buy
8,608
+262
+3% +$15.9K 0.49% 36
2016
Q4
$469K Buy
8,346
+188
+2% +$11K 0.48% 33
2016
Q3
$486K Buy
8,158
+628
+8% +$36.7K 0.51% 32
2016
Q2
$414K Hold
7,530
0.45% 32
2016
Q1
$380K Hold
7,530
0.42% 35
2015
Q4
$380K Buy
+7,530
New +$380K 0.43% 35

Other funds holding MRK

Day & Ennis's MRK Position: Q4 2023 in Review

Day & Ennis increased its Merck (MRK) stake by 0.01% in Q4 2023, buying an estimated $104 and bringing the position to 8,108 shares worth $884K. The position accounts for 0.31% of the portfolio, ranked #58.

Day & Ennis first reported a position in MRK in Q4 2015 and has held it in 30 quarters since. The position peaked at $935K in Q2 2023. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Day & Ennis held 8,108 shares of Merck worth $884K as of Q4 2023.
  • Day & Ennis bought 1 Merck share in Q4 2023, an estimated $104.
  • Merck made up 0.31% of Day & Ennis's portfolio in Q4 2023, its #58 holding.
  • Day & Ennis first reported a position in Merck in Q4 2015 and has held it in 30 quarters since.
  • Day & Ennis's Merck position peaked at $935K in Q2 2023.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Day & Ennis's 13F filing for Q4 2023, filed 18 Jan 2024.